Medical Information
India
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for India Healthcare Professionals. Would you like to proceed?

I am a healthcare professional registered to practice in IndiaYes, I am a healthcare professional
SelectI am a healthcare professional registered to practice in IndiaYes, I am a healthcare professional
I am a patient/caregiver residing in IndiaNo, go back to the patient portal
SelectI am a patient/caregiver residing in IndiaNo, go back to the patient portal
Non-India residents click here.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.
Poster
DD Pittman, S Rakhe, J McKay, P Gaitonde, J Rupon May 8, 2022 WFH 2022 Hemophilia

Analysis of FIX Activity Following Addition of Exogenous FIX to Plasma From Participants Treated With Fidanacogene Elaparvovec

View Presentation
Poster
LE Markson, L Young, L Ban, Y Chen, PF Fogarty May 8, 2022 WFH 2022 Hemophilia

Healthcare Resource Use, Depression, and Anxiety Among Adult Males With Hemophilia B: Observed Differences for Those With and Without Medically Recorded Bleeding Episodes in the United States

View Presentation
Mini-Oral Presentation
Pittman D, Carrieri C, Soares H, McKay J, Tan C, Liang J, Rakhe S, Marshall JC, Murphy J, Rupon J May 8, 2022 WFH 2022 Hemophilia

Preliminary field study results suggest differences in FIX activity based on assay from gene therapy trial patients expressing R338L high-activity variant of FIX

View Presentation
Oral Presentation
Debra Pittman July 9, 2022 ISTH 2022 Hemophilia

Effect of Growth on AAV-mediated Expression of FIX-R338L in Juvenile Hemophilia B Dogs

View Presentation
Poster
Patrick F Fogarty, Brinda K Tammara, Justin Smith, Delphine Agathon, Florence Ganne, Frank Plonski, Jeremy Rupon August 16, 2022 THSNA 2022 Hemophilia

Clearance of Giroctocogene Fitelparvovec Vector DNA in Adults With Severe Hemophilia A

View Presentation
Poster
John Teeter, Robert Charnigo, Nandini Cossons, Sangeeta Raje, Eunhee Hwang, Thomas Le Duigou August 25, 2022 NHF 2022 Hemophilia

Safety and Efficacy of Marstacimab for Prevention of Bleeding Episodes in Pediatric Patients With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B With or Without Inhibitors

View Presentation
Poster
Debra D Pittman, Charles Carrieri, Holly Soares, John McKay, Charles Tan, John Liang, Swapnil Rakhe, Jean-Claude Marshall, John Murphy, Jeremy Rupon August 26, 2022 NHF 2022 Hemophilia

Preliminary Field Study Results Suggest Differences in FIX Activity Based on Assay From Gene Therapy Trial Patients Expressing R338L High-Activity Variant of FIX

View Presentation
Poster
Y. GU, K. HUANG, X. SUN, X. ZHOU, R. SHEN, L. Young, A. CHHABRA, G. DIRUSSO, J. RUPON and I. WINBURN December 10, 2022 ASH 2022 Hemophilia

A Retrospective Cohort Study of Switching Patterns among Hemophilia A and B Patients using Optum Electronic Health Records (EHR) Database in the United States (US)

View Presentation
Poster
John Rasko, George Bashirians, Christos J Petropoulos, Terri Wrin, Yuvika Paliwal, Peter V Henstock, Suryanarayan Somanathan, Michelle Casey, Candida da Fonseca Pereira, Ian Winburn, Amit Chhabra December 10, 2022 ASH 2022 Hemophilia

Global Seroprevalence of Neutralizing Antibodies Against Adeno-Associated Virus (AAV) Serotypes of Relevance to Gene Therapy

View Presentation
Poster
Adam Giermasz, Nathan Visweshwar, Thomas J Harrington, Andrew D Leavitt, Barbara A Konkle, Jeremy Rupon, Gregory Di Russo, Li-Jung Tseng, Maria de los Angeles Resa, Florence Ganne, Delphine Agathon, Frank Plonski, Didier Rouy, Bettina M Cockroft, Annie Fang, Steven Arkin December 10, 2022 ASH 2022 Hemophilia

Updated Results of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (PF-07055480/SB-525) Gene Therapy in Adults With Severe Hemophilia A

View Presentation